AstraZeneca (AZNCF)

AI Score

Unlock

132.38

-7.42 (-5.31%)

At close: Apr 21, 2025, 3:52 PM

AstraZeneca Income Statement

Financials in USD. Fiscal year is undefined.

Fiscal Year	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022	Q2 2022	Q1 2022	Q4 2021	Q3 2021	Q2 2021	Q1 2021	Q4 2020	Q3 2020	Q2 2020	Q1 2020	Q4 2019	Q3 2019	Q2 2019	Q1 2019	Q4 2018	Q3 2018	Q2 2018	Q1 2018	Q4 2017	Q3 2017	Q2 2017	Q1 2017	Q4 2016	Q3 2016	Q2 2016	Q1 2016
Period Ending	Dec 31, 2024	Sep 30, 2024	Jun 30, 2024	Mar 31, 2024	Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021	Dec 31, 2020	Sep 30, 2020	Jun 30, 2020	Mar 31, 2020	Dec 31, 2019	Sep 30, 2019	Jun 30, 2019	Mar 31, 2019	Dec 31, 2018	Sep 30, 2018	Jun 30, 2018	Mar 31, 2018	Dec 31, 2017	Sep 30, 2017	Jun 30, 2017	Mar 31, 2017	Dec 31, 2016	Sep 30, 2016	Jun 30, 2016	Mar 31, 2016
Revenue	14.89B	13.56B	12.96B	12.62B	12.34B	11.49B	11.42B	10.88B	11.21B	10.98B	10.77B	11.39B	12.01B	9.87B	8.22B	7.32B	7.41B	6.58B	6.28B	6.35B	6.66B	6.41B	5.82B	5.49B	6.42B	5.34B	5.16B	5.18B	5.78B	6.23B	5.05B	5.41B	5.58B	5.7B	5.6B	6.12B
Cost of Revenue	2.73B	3.08B	3.15B	3.13B	3.38B	2.1B	1.96B	1.91B	2.9B	2.98B	3B	3.51B	4.63B	3.76B	2.19B	1.86B	1.52B	1.37B	984M	1.42B	1.38B	1.35B	1.06B	1.13B	1.64B	1.15B	1.01B	1.13B	1.23B	1.25B	950M	894M	1.16B	900M	1.06B	1B
Gross Profit	12.17B	10.48B	9.81B	9.49B	8.96B	9.4B	9.46B	8.97B	8.31B	8B	7.77B	7.88B	7.39B	6.11B	6.03B	5.46B	5.88B	5.21B	5.29B	4.93B	5.29B	5.05B	4.76B	4.36B	4.78B	4.19B	4.14B	4.04B	4.55B	4.98B	4.1B	4.51B	4.42B	4.8B	4.54B	5.11B
Operating Income	2.04B	2.11B	2.85B	3.23B	1.32B	1.95B	2.46B	2.55B	1.09B	1.25B	539M	878M	-292M	-1.67B	1.13B	1.9B	1.49B	1.17B	1.28B	1.22B	577M	757M	493M	1.1B	1.08B	851M	763M	696M	686M	1.15B	925M	917M	2.53B	1.03B	303M	1.04B
Interest Income	64M	183M	100M	111M	110.82M	101M	64M	78M	45M	15M	18M	17M	1M	15M	7M	20M	7M	7M	22M	51M	39M	37M	41M	55M	26M	34M	43M	35M	49M	32M	28M	18M	23M	13M	17M	14M
Pretax Income	1.67B	1.83B	2.4B	2.8B	920.42M	1.65B	2.09B	2.26B	778M	922M	247M	553M	-636M	-2B	764M	1.61B	1.17B	853M	961M	935M	240M	409M	141M	758M	730M	477M	412M	374M	407M	746M	492M	582M	2.18B	676M	-30M	723M
Net Income	1.5B	1.43B	1.93B	2.18B	960M	1.37B	1.82B	1.8B	901M	1.64B	360M	386M	-347M	-1.65B	550M	1.56B	1.01B	648M	756M	780M	313M	299M	130M	593M	1.03B	431M	350M	340M	1.3B	686M	477M	537M	1.84B	1.01B	-3M	646M
Selling & General & Admin	5.55B	5.29B	5.06B	3.58B	4.65B	4.93B	5.12B	4.19B	4.78B	3.29B	4.81B	4.96B	5.24B	2.99B	3.2B	3.03B	3.32B	2.27B	2.74B	2.81B	3.09B	3.25B	3.02B	2.59B	2.69B	2.5B	2.63B	2.54B	3.16B	2.57B	2.43B	2.38B	1.47B	2.48B	3.14B	2.65B
Research & Development	4.68B	3.12B	3.01B	2.69B	2.99B	2.58B	2.67B	2.61B	2.63B	2.36B	2.55B	2.13B	2.58B	2.15B	1.83B	1.71B	1.72B	1.45B	1.39B	1.39B	2.07B	1.33B	1.36B	1.27B	2.01B	1.28B	1.36B	1.28B	1.55B	1.4B	1.35B	1.45B	1.54B	1.4B	1.47B	1.48B
Other Expenses	-100M	-25M	-3M	0.03	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	1M	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Operating Expenses	10.13B	8.38B	8.01B	6.26B	7.64B	7.44B	7B	6.67B	7.21B	6.59B	7.23B	7B	7.68B	7.44B	4.9B	3.56B	4.4B	3.89B	4.01B	3.71B	4.66B	4.24B	4.27B	3.27B	3.7B	3.34B	3.38B	3.35B	3.87B	3.83B	3.18B	3.59B	1.89B	3.77B	4.24B	4.07B
Interest Expense	429M	457M	443M	413M	456.62M	392M	431M	365M	360M	339M	311M	336M	336M	335M	326M	303M	321M	324M	329M	332M	351M	353M	361M	367M	337M	364M	375M	343M	316M	418M	448M	340M	362M	355M	342M	325M
Selling & Marketing Expenses	143M	145M	132M	135M	17.83B	4.93B	5.12B	4.19B	4.78B	3.29B	4.81B	4.96B	5.24B	2.99B	3.2B	3.03B	3.32B	2.27B	2.74B	2.81B	3.09B	3.25B	3.02B	2.59B	2.69B	2.5B	2.63B	2.54B	3.16B	2.57B	2.43B	2.38B	1.47B	2.48B	3.14B	2.65B
Cost & Expenses	12.86B	11.46B	10.19B	9.39B	11.02B	9.54B	8.96B	8.57B	10.11B	9.57B	10.23B	10.51B	12.3B	11.2B	7.09B	5.42B	5.92B	5.26B	4.99B	5.13B	6.04B	5.59B	5.33B	4.39B	5.34B	4.49B	4.39B	4.48B	5.09B	5.08B	4.13B	4.49B	3.05B	4.67B	5.3B	5.08B
Income Tax Expense	166M	395M	469M	617.24M	-63.62M	274M	268M	458M	-124M	-720M	-113M	165M	-290M	-350M	214M	46M	162M	202M	223M	185M	-37M	129M	34M	195M	-279M	71M	93M	58M	-854M	97M	46M	70M	366M	-319M	1M	98M
Shares Outstanding (Basic)	1.55B	1.55B	1.55B	1.55B	1.55B	1.55B	1.55B	1.55B	1.55B	1.55B	1.55B	1.55B	1.55B	1.5B	1.31B	1.31B	1.31B	1.31B	1.31B	1.31B	1.31B	1.31B	1.31B	1.27B	1.27B	1.27B	1.27B	1.27B	1.27B	1.27B	1.27B	1.26B	1.26B	1.26B	1.26B	1.26B
Shares Outstanding (Diluted)	1.56B	1.56B	1.56B	1.56B	1.56B	1.56B	1.56B	1.56B	1.56B	1.56B	1.56B	1.56B	1.55B	1.5B	1.32B	1.32B	1.31B	1.31B	1.31B	1.31B	1.31B	1.31B	1.31B	1.27B	1.27B	1.27B	1.27B	1.27B	1.27B	1.27B	1.27B	1.27B	1.27B	1.27B	1.26B	1.26B
EPS (Basic)	0.97	0.92	1.24	1.40	0.64	0.85	1.19	1.18	0.60	1.06	0.23	0.25	-0.22	-1.1	0.42	1.19	0.78	0.49	0.58	0.59	0.24	0.23	0.09	0.47	0.82	0.34	0.27	0.27	1.03	0.54	0.38	0.42	1.46	0.80	-0.00	0.51
EPS (Diluted)	0.96	0.91	1.24	1.39	0.63	0.85	1.18	1.17	0.60	1.05	0.23	0.25	-0.22	-1.1	0.42	1.18	0.78	0.49	0.58	0.59	0.24	0.23	0.09	0.47	0.82	0.34	0.27	0.27	1.03	0.54	0.38	0.42	1.45	0.80	-0.00	0.51
EBITDA	4.43B	4.1B	4.12B	4.46B	2.68B	3.22B	3.85B	3.89B	2.38B	2.46B	1.86B	2.16B	1.91B	1.1B	1.86B	2.71B	2.25B	1.98B	2B	2.11B	2.2B	1.47B	1.22B	1.77B	2.68B	1.63B	1.54B	1.5B	1.68B	1.95B	1.73B	1.89B	2.54B	1.89B	1.2B	1.76B
EBIT	2.1B	2.29B	2.84B	3.21B	1.3B	1.98B	2.46B	2.63B	1.12B	1.25B	539M	876.5M	-291.88M	-1.67B	1.12B	1.91B	1.45B	1.17B	1.28B	1.22B	561M	762M	502M	1.13B	1.01B	841M	787M	717M	568M	1.16B	940M	922M	2.53B	1.03B	312M	1.05B
Depreciation & Amortization	2.34B	1.82B	1.28B	1.25B	1.36B	1.24B	1.29B	1.52B	1.53B	1.27B	1.32B	1.28B	2.2B	2.73B	743.79M	797.47M	797M	801M	710M	841M	1.64B	716M	727M	676M	1.66B	698M	684M	709M	1.11B	655M	616M	658M	590M	611M	587M	569M